1W7H

p38 Kinase crystal structure in complex with small molecule inhibitor

Summary for 1W7H

• Entry DOI: 10.2210/pdb1w7h/pdb
• Related: 1A9U 1BL6 1BL7 1BMK 1DI9 1IAN 1KV1 1KV2 1M7Q 1OUK 1OUY 1OVE 1OZ1 1R39 1R3C 1W82 1W83 1W84 1WFC
• Descriptor: MITOGEN-ACTIVATED PROTEIN KINASE 14, 3-(BENZYLOXY)PYRIDIN-2-AMINE (3 entities in total)
• Functional Keywords: p38, kinase, inhibitor complex, phosphorylation, serine/threonine-protein kinase, transferase
• Biological source: HOMO SAPIENS (HUMAN)
• Cellular location: Cytoplasm : Q16539
• Total number of polymer chains: 1
• Total formula weight: 41543.43

Authors

Jhoti, H.,Gill, A.,Cleasby, A.,Devine, L. (deposition date: 2004-09-02, release date: 2005-02-08, Last modification date: 2023-12-13)

Primary citation

Hartshorn, M.J.,Murray, C.W.,Cleasby, A.,Frederickson, M.,Tickle, I.J.,Jhoti, H.
Fragment-Based Lead Discovery Using X-Ray Crystallography
J.Med.Chem., 48:403-, 2005

PubMed Abstract: Fragment screening offers an alternative to traditional screening for discovering new leads in drug discovery programs. This paper describes a fragment screening methodology based on high throughput X-ray crystallography. The method is illustrated against five proteins (p38 MAP kinase, CDK2, thrombin, ribonuclease A, and PTP1B). The fragments identified have weak potency (>100 microM) but are efficient binders relative to their size and may therefore represent suitable starting points for evolution to good quality lead compounds. The examples illustrate that a range of molecular interactions (i.e., lipophilic, charge-charge, neutral hydrogen bonds) can drive fragment binding and also that fragments can induce protein movement. We believe that the method has great potential for the discovery of novel lead compounds against a range of targets, and the companion paper illustrates how lead compounds have been identified for p38 MAP kinase starting from fragments such as those described in this paper.

PubMed: 15658854
DOI: 10.1021/JM0495778

Experimental method

X-RAY DIFFRACTION (2.214 Å)